ClinConnect ClinConnect Logo
Search / Trial NCT06206161

Optimizing and Advancing SBIRT in Schools

Launched by MASSACHUSETTS GENERAL HOSPITAL · Jan 4, 2024

Trial Information

Current as of July 09, 2025

Enrolling by invitation

Keywords

Alcohol Use Screening, Brief Intervention, Referral To Treatment (Sbirt) Prevention Expanded Workforce

ClinConnect Summary

Massachusetts is the only state in the United States that mandates annual Screening, Brief Intervention and Referral to Treatment (SBIRT) assessments in public middle and high schools. SBIRT includes administering a validated screening instrument (CRAFFT + N) to all students in a single grade and then, based on responses on the screen, delivering a brief intervention (BI) to increase motivation to reduce substance use. While SBIRT represents a positive step in utilizing schools to enhance youth health, current BI implementation has limitations. Firstly, robust BIs primarily target youth alr...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Enrolled in a participating high school and in the grade scheduled to receive SBIRT
  • Exclusion Criteria:
  • Passive consent declined by parent/guardian through the opt-out model

About Massachusetts General Hospital

Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.

Locations

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Randi M Schuster, PhD

Principal Investigator

Massachusetts General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported